2 beaten down ASX growth shares analysts believe are great value

These ASX growth shares could be quality options…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It is fair to say that 2022 has not been kind to growth shares. But every cloud has a silver lining.

On this occasion, that silver lining is that a number of quality shares are trading at a significant discount to where they traded just three months ago.

Here's why these beaten down ASX growth shares could be in the buy zone now:

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

Image source: Getty Images

Life360 Inc (ASX: 360)

The first ASX share to look at is Life360. It is a location-based services provider based in San Francisco, United States with 33 million+ monthly active users. Its shares have lost almost half of their value since the start of the year after investors abandoned growth shares and particularly those that were not yet profitable.

The team at Bell Potter believe this is a buying opportunity and remain very positive on its long term outlook. Particularly given its opportunity to monetise is massive user base and its robust balance sheet. The broker believes the latter is more than sufficient to see Life360 through to profitability.

Bell Potter currently has a buy rating and $10.00 price target on its shares. This is almost double where its shares trade at today.

Xero Limited (ASX: XRO)

Another ASX growth share that could be in the buy zone is Xero. It is a leading cloud-based business and accounting software provider which boasts over 3 million subscribers globally.

Xero's shares have also fallen heavily in 2022 and are now down by approximately a third since the turn of the year.

Analysts at Goldman Sachs see this as a buying opportunity for investors, noting that its shares are trading close to pre-COVID levels. This is despite the cloud accounting company being in a much stronger position now and the broker expecting a 24% compound annual growth rate for Xero's gross profit between FY 2021 and FY 2025

As a result, Goldman recently retained its buy rating with a trimmed price target of $135.00.

Motley Fool contributor James Mickleboro owns Life360, Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Life360, Inc. and Xero. The Motley Fool Australia owns and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A golden egg with dividend cash flying out of it
Growth Shares

Forget Easter eggs, these ASX shares could be your best buys this month

These shares could be top buys after the Easter break.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 amazing ASX growth shares I'd buy and hold for the next decade

These shares could be worth holding tightly to for the long term.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Growth Shares

$5,000 invested in Droneshield shares 4 months ago is already worth…

Investors will be thrilled!

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

1 ASX dividend share and 1 ASX growth stock to buy in April

These ASX shares deliver a one-two punch: income now, growth later.

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »

Scared people on a rollercoaster holding on for dear life, indicating a plummeting share price
Growth Shares

3 reasons to buy this red-hot ASX healthcare stock today

Brokers think the biotech share is gearing up for its next big move.

Read more »

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
Growth Shares

2 ASX stocks that could help turn $10,000 into $1 million

I’d think about adding these ASX shares to your portfolio.

Read more »

Part of male mannequin dressed in casual clothes holding a sale paper shopping bag.
Growth Shares

2 ASX financial stocks that could double – or even triple – in value

If sentiment turns and execution delivers, this could be an opportunity investors won’t want to miss.

Read more »